IM To compare the efficacy between a combined chemotherapy of ACNU (nimustine hydrochloride, brand name Nidran), a new nitrosourea agent, and a combined chemotherapy of methylCCNU for advanced gastric cancer.METHOD ...IM To compare the efficacy between a combined chemotherapy of ACNU (nimustine hydrochloride, brand name Nidran), a new nitrosourea agent, and a combined chemotherapy of methylCCNU for advanced gastric cancer.METHOD One hundred and three cases of advanced gastric cancer were randomly allocated into Group A (MeCCNU, 5FU and ADM) and Group B (ACNU, 5FU and ADM). The quality of life (QOL) questionnaire composed of 11 ordinal categorical items was studied in these patients.RESULTS In Group A there was no complete remission (CR) or partial remission (PR), while in Group B, although there was no CR, there were 8 PR (8/46 cases), denoting the response rate of 0% in Group A and 174% in Group B. The median survival time in Group A was 108 days and in Group B 112 days. Both groups tolerated well during the treatment and there were no serious adverse effects. QOL evaluations showed better psychological and physical feelings of tiredness in Group B than in Group A, and scores of face scale had more pleasant inclination.CONCLUSION ACNU combination is superior to MeCCNU combination for advanced gastric cancer.展开更多
文摘IM To compare the efficacy between a combined chemotherapy of ACNU (nimustine hydrochloride, brand name Nidran), a new nitrosourea agent, and a combined chemotherapy of methylCCNU for advanced gastric cancer.METHOD One hundred and three cases of advanced gastric cancer were randomly allocated into Group A (MeCCNU, 5FU and ADM) and Group B (ACNU, 5FU and ADM). The quality of life (QOL) questionnaire composed of 11 ordinal categorical items was studied in these patients.RESULTS In Group A there was no complete remission (CR) or partial remission (PR), while in Group B, although there was no CR, there were 8 PR (8/46 cases), denoting the response rate of 0% in Group A and 174% in Group B. The median survival time in Group A was 108 days and in Group B 112 days. Both groups tolerated well during the treatment and there were no serious adverse effects. QOL evaluations showed better psychological and physical feelings of tiredness in Group B than in Group A, and scores of face scale had more pleasant inclination.CONCLUSION ACNU combination is superior to MeCCNU combination for advanced gastric cancer.
